DK130382A - Fremgangsmaade til fremstilling af quinolinderivater eller salte deraf - Google Patents

Fremgangsmaade til fremstilling af quinolinderivater eller salte deraf Download PDF

Info

Publication number
DK130382A
DK130382A DK130382A DK130382A DK130382A DK 130382 A DK130382 A DK 130382A DK 130382 A DK130382 A DK 130382A DK 130382 A DK130382 A DK 130382A DK 130382 A DK130382 A DK 130382A
Authority
DK
Denmark
Prior art keywords
salts
procedure
production
quinoline derivatives
quinoline
Prior art date
Application number
DK130382A
Other languages
English (en)
Other versions
DK159427B (da
DK159427C (da
Inventor
R Goeschke
P G Ferrini
A Sallmann
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK130382A publication Critical patent/DK130382A/da
Publication of DK159427B publication Critical patent/DK159427B/da
Application granted granted Critical
Publication of DK159427C publication Critical patent/DK159427C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/241,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • C07D265/26Two oxygen atoms, e.g. isatoic anhydride
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/38Oxygen atoms in positions 2 and 3, e.g. isatin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK130382A 1981-03-24 1982-03-23 Analogifremgangsmaade til fremstilling af antiallergisk virksomme quinolinonderivater eller salte deraf DK159427C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH198681 1981-03-24
CH198681 1981-03-24

Publications (3)

Publication Number Publication Date
DK130382A true DK130382A (da) 1982-09-25
DK159427B DK159427B (da) 1990-10-15
DK159427C DK159427C (da) 1991-03-18

Family

ID=4223231

Family Applications (1)

Application Number Title Priority Date Filing Date
DK130382A DK159427C (da) 1981-03-24 1982-03-23 Analogifremgangsmaade til fremstilling af antiallergisk virksomme quinolinonderivater eller salte deraf

Country Status (22)

Country Link
US (1) US4476132A (da)
EP (1) EP0062001B1 (da)
JP (1) JPH066576B2 (da)
AR (4) AR242189A1 (da)
AT (1) ATE27451T1 (da)
AU (1) AU560003B2 (da)
CY (1) CY1412A (da)
DE (1) DE3276432D1 (da)
DK (1) DK159427C (da)
ES (7) ES8400092A1 (da)
FI (1) FI77853C (da)
GB (1) GB2095668B (da)
GR (1) GR78345B (da)
HK (1) HK3988A (da)
HU (1) HU192103B (da)
IE (1) IE53158B1 (da)
IL (1) IL65327A0 (da)
MY (1) MY8700806A (da)
NO (1) NO160074C (da)
NZ (1) NZ200106A (da)
PT (1) PT74634B (da)
ZA (1) ZA821957B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58219166A (ja) * 1982-06-14 1983-12-20 Nippon Shinyaku Co Ltd 4−キノロン誘導体
JPS58225065A (ja) * 1982-06-21 1983-12-27 Nippon Shinyaku Co Ltd 2−キノロン誘導体
US4675432A (en) * 1986-08-29 1987-06-23 American Cyanamid Company Method for the preparation of anilinofumarate
US6034100A (en) * 1993-03-10 2000-03-07 Otsuka Pharmaceutical Co., Ltd. Method for inhibiting cytokine secretion
HUP0302167A3 (en) * 2000-10-02 2010-03-29 Janssen Pharmaceutica Nv Quinoline derivatives as metabotropic glutamate receptor antagonists, pharmaceutical compositions containing them and process for producing them
JP4573533B2 (ja) * 2002-03-29 2010-11-04 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 放射能標識付きキノリンおよびキノリノン誘導体および代謝向性グルタメート受容体リガンドとしてのそれらの使用
EP2909192B1 (en) 2012-10-16 2017-05-17 Janssen Pharmaceutica NV Methylene linked quinolinyl modulators of ror-gamma-t
BR112015008515A2 (pt) 2012-10-16 2017-07-04 Janssen Pharmaceutica Nv moduladores de ror t de quinolinila ligada à heteroarila
SG11201502935VA (en) 2012-10-16 2015-09-29 Janssen Pharmaceutica Nv Phenyl linked quinolinyl modulators of ror-gamma-t
US10555941B2 (en) 2013-10-15 2020-02-11 Janssen Pharmaceutica Nv Alkyl linked quinolinyl modulators of RORγt
US9403816B2 (en) 2013-10-15 2016-08-02 Janssen Pharmaceutica Nv Phenyl linked quinolinyl modulators of RORγt
US9221804B2 (en) 2013-10-15 2015-12-29 Janssen Pharmaceutica Nv Secondary alcohol quinolinyl modulators of RORγt
ES2770727T3 (es) 2013-10-15 2020-07-02 Janssen Pharmaceutica Nv Moduladores de quinilonila enlazados a alquilo de ROR(gamma)t
CN105848483A (zh) 2013-10-15 2016-08-10 詹森药业有限公司 RORγt 的喹啉基调节剂
US9284308B2 (en) 2013-10-15 2016-03-15 Janssen Pharmaceutica Nv Methylene linked quinolinyl modulators of RORγt
US9328095B2 (en) 2013-10-15 2016-05-03 Janssen Pharmaceutica Nv Heteroaryl linked quinolinyl modulators of RORgammat

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB830832A (en) * 1957-02-15 1960-03-23 Ici Ltd New quinolones and therapeutic compositions containing them
GB1013224A (en) * 1962-06-21 1965-12-15 Ici Ltd Heterocyclic aminoethanols
CH538476A (de) * 1966-09-29 1973-06-30 Ciba Geigy Ag Verfahren zur Herstellung von heterocyclischen Carbonsäuren
US3496184A (en) * 1969-03-18 1970-02-17 Ciba Geigy Corp Cyclopropylmethoxy-3-quinoline carboxylic acids and esters
NL7101049A (da) * 1970-01-28 1971-07-30
GB1334705A (en) * 1970-06-19 1973-10-24 Ici Ltd Pharmaceutical compositions containing kynurenic acid derivatives
CA942748A (en) * 1970-09-18 1974-02-26 Venkatachala L. Narayanan 1-aziridinylcarbonyl substituted-3-quinolinecarboxylic acid compounds
US4190659A (en) * 1973-08-27 1980-02-26 Sandoz, Inc. Pharmaceutical preparation and use of 4-hydroxy-2-quinolinone-3-carboxylic acid esters
US4086349A (en) * 1975-07-30 1978-04-25 Mitsubishi Yuka Pharmaceutical Co., Ltd. Quinolopyran-4-one-2-carboxylic acid derivatives and salts thereof as novel compounds and as medicines for treatment of allergic asthma
JPS609511B2 (ja) * 1976-07-16 1985-03-11 大塚製薬株式会社 5−カルボスチリルメタノ−ル誘導体
JPS609713B2 (ja) * 1976-10-08 1985-03-12 大塚製薬株式会社 カルボスチリル誘導体
US4186201A (en) * 1977-02-07 1980-01-29 Riker Laboratories, Inc. Methods of using 8(tetrazol-5-ylcarbamoyl)isoquinoline compounds
US4187309A (en) * 1977-06-20 1980-02-05 Sandoz, Inc. 4-Hydroxy-2-quinolinone-3-carboxylic acids and salts thereof
US4119720A (en) * 1977-07-06 1978-10-10 Sandoz, Inc. Unsaturated esters of 4-hydroxy-2-quinolinone-3-carboxylic acids and salts thereof
DE2806879A1 (de) * 1978-02-17 1979-08-23 Sandoz Ag 4-hydroxy-2-chinolinon-3-carbonsaeure- esterderivate

Also Published As

Publication number Publication date
AU8181982A (en) 1982-09-30
FI820983L (fi) 1982-09-25
JPH066576B2 (ja) 1994-01-26
FI77853B (fi) 1989-01-31
NO160074C (no) 1989-03-08
HU192103B (en) 1987-05-28
CY1412A (en) 1988-04-22
JPS57192366A (en) 1982-11-26
ES523339A0 (es) 1985-03-01
AR242189A1 (es) 1993-03-31
ES8503662A1 (es) 1985-03-01
NO160074B (no) 1988-11-28
ES8503334A1 (es) 1985-02-16
ES523341A0 (es) 1985-02-16
FI77853C (fi) 1989-05-10
AR242376A1 (es) 1993-03-31
EP0062001A3 (en) 1983-01-26
ATE27451T1 (de) 1987-06-15
EP0062001B1 (de) 1987-05-27
IL65327A0 (en) 1982-05-31
US4476132A (en) 1984-10-09
DK159427B (da) 1990-10-15
ES8503663A1 (es) 1985-03-01
ES8503661A1 (es) 1985-03-01
NO820959L (no) 1982-09-27
HK3988A (en) 1988-01-22
GB2095668A (en) 1982-10-06
ES510685A0 (es) 1983-10-16
GR78345B (da) 1984-09-26
GB2095668B (en) 1985-04-11
ES8400092A1 (es) 1983-10-16
PT74634B (de) 1984-11-26
DE3276432D1 (en) 1987-07-02
IE820670L (en) 1982-09-24
ES523337A0 (es) 1985-03-01
ZA821957B (en) 1983-02-23
MY8700806A (en) 1987-12-31
ES523342A0 (es) 1985-03-01
EP0062001A2 (de) 1982-10-06
AR240739A1 (es) 1990-10-31
AR240044A1 (es) 1990-01-31
ES8503665A1 (es) 1985-03-01
NZ200106A (en) 1985-07-31
ES523338A0 (es) 1985-03-01
IE53158B1 (en) 1988-08-03
ES523340A0 (es) 1985-03-01
ES8503664A1 (es) 1985-03-01
AU560003B2 (en) 1987-03-26
PT74634A (de) 1982-04-01
DK159427C (da) 1991-03-18

Similar Documents

Publication Publication Date Title
DK28282A (da) Fremgangsmaade til fremstilling af hexapyranoseforbindelser eller salte deraf
DK130382A (da) Fremgangsmaade til fremstilling af quinolinderivater eller salte deraf
DK160561C (da) Analogifremgangsmaade til fremstilling af 3-aminopregn-5-enderivater eller salte deraf
DK503080A (da) Fremgangsmaade til fremstilling af imdazolderivater eller salte deraf
DK491582A (da) Fremgangsmaade til fremstilling af morphinanderivater
DK162991C (da) Analogifremgangsmaade til fremstilling af thiazolidinylalkylenpiperazinderivater
DK352082A (da) Fremgangsmaade til fremstilling af ergopeptinderivater
DK493083A (da) Fremgangsmaade til fremstilling af 4-oxo-1,4-dihydronicotinsyrederivater eller salte deraf
DK276582A (da) Fremgangsmaade til fremstilling af cephemderivater
DK163580C (da) Analogifremgangsmaade til fremstilling af cyclohexancarboxylsyrederivater
DK335882A (da) Fremgangsmaade til fremstilling af cephemderivater
DK160555C (da) Fremgangsmaade til fremstilling af eburnamoninderivater
DK505482A (da) Fremgangsmaade til fremstilling af pyridinderivater
DK324979A (da) Fremgangsmaade til fremstilling af imidazoquinoxaliner eller salte deraf
DK116982A (da) Fremgangsmaade til fremstilling af alkylendioxybenzenderivater
DK427083A (da) Fremgangsmaade til fremstilling af cephemderivater
DK438482A (da) Fremgangsmaade til fremstilling af indanderivater eller syreadditionssalte deraf
DK158227C (da) Analogifremgangsmaade til fremstilling af substituerede imidazooe1,5-aaapyridiner eller 5,6,7,8-tetrahydroderivater deraf eller salte deraf
DK156219C (da) Analogifremgangsmaade til fremstilling af spirothiazolidinylpiperazinderivater
DK224381A (da) Fremgangsmaade til fremstilling af benzazolderivater eller salte deraf
DK375882A (da) Fremgangsmaade til fremstilling af benzisoxazolderivater
DK553982A (da) Fremgangsmaade til fremstilling af omt-esterderivater eller syreadditionssalte deraf
DK149823C (da) Fremgangsmaade til fremstilling af kijanimicin eller farmaceutisk acceptable salte heraf
DK476082A (da) Fremgangsmaade til fremstilling af phenolderivater eller salte deraf
DK70482A (da) Fremgangsmaade til fremstilling af diazolderivater

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment
PBP Patent lapsed